Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art
December 2023
in “
̒Ulūm-i dārūyī
”
hirsutism androgens polycystic ovarian syndrome Cushing syndrome insulin resistance congenital adrenal hyperplasia ovarian tumors adrenal tumors menopause oral contraceptives antiandrogen therapy spironolactone cyproterone acetate flutamide finasteride insulin-lowering medicines gonadotrophin-releasing hormone agonists eflornithine hydrochloride cream nanostructured lipid carriers solid lipid nanoparticles liposomes cerosomes nanogel PCOS birth control pills Aldactone Androcur Eulexin Propecia Vaniqa NLC SLN
Studysummary This review provides a comprehensive examination of the causes and treatments for hirsutism in women, highlighting the role of pharmacological therapies and novel nanotechnology-based methods in improving patient quality of life.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ps.tbzmed.ac.ir →